451 related articles for article (PubMed ID: 28664547)
41. Valsartan ameliorates podocyte loss in diabetic mice through the Notch pathway.
Gao F; Yao M; Cao Y; Liu S; Liu Q; Duan H
Int J Mol Med; 2016 May; 37(5):1328-36. PubMed ID: 26985716
[TBL] [Abstract][Full Text] [Related]
42. C-peptide ameliorates high glucose-induced podocyte dysfunction through the regulation of the Notch and TGF-β signaling pathways.
Luo J; Jiang J; Huang H; Jiang F; Xu Z; Zhou Z; Zhu H
Peptides; 2021 Aug; 142():170557. PubMed ID: 33901627
[TBL] [Abstract][Full Text] [Related]
43. [Effects of ferulic acid on the expressions of nephrin and podocin in podocytes of diabetic rats].
Wang XT; Pan DY; Guo W; Chen SS; Zhou B; Yang JJ; Qi MY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Jun; 33(6):564-567. PubMed ID: 29931909
[TBL] [Abstract][Full Text] [Related]
44. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
[TBL] [Abstract][Full Text] [Related]
45. FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression.
Ma R; Liu L; Jiang W; Yu Y; Song H
Int J Clin Exp Pathol; 2015; 8(11):14063-74. PubMed ID: 26823720
[TBL] [Abstract][Full Text] [Related]
46. Effect of arctiin on glomerular filtration barrier damage in STZ-induced diabetic nephropathy rats.
Ma ST; Liu DL; Deng JJ; Niu R; Liu RB
Phytother Res; 2013 Oct; 27(10):1474-80. PubMed ID: 23147865
[TBL] [Abstract][Full Text] [Related]
47. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
[TBL] [Abstract][Full Text] [Related]
48. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
[TBL] [Abstract][Full Text] [Related]
49. GLCCI1 is a novel component associated with the PI3K signaling pathway in podocyte foot processes.
Kim SH; Kim HJ; Kim CW
Exp Mol Med; 2016 May; 48(5):e233. PubMed ID: 27174202
[TBL] [Abstract][Full Text] [Related]
50. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury.
Zhang J; Fu H; Xu Y; Niu Y; An X
J Nat Med; 2016 Oct; 70(4):740-8. PubMed ID: 27255369
[TBL] [Abstract][Full Text] [Related]
51. [Effects of angiotensin II receptor antagonist on rat podocyte injury in early diabetic nephropathy].
Long HB; Zhong J; Wei LB; Zhou WD; Xu ZZ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):505-8. PubMed ID: 17545045
[TBL] [Abstract][Full Text] [Related]
52. The reno-protective effect of a phosphoinositide 3-kinase inhibitor wortmannin on streptozotocin-induced proteinuric renal disease rats.
Kim SH; Jang YW; Hwang P; Kim HJ; Han GY; Kim CW
Exp Mol Med; 2012 Jan; 44(1):45-51. PubMed ID: 22056625
[TBL] [Abstract][Full Text] [Related]
53. Macrophages directly mediate diabetic renal injury.
You H; Gao T; Cooper TK; Brian Reeves W; Awad AS
Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1719-27. PubMed ID: 24173355
[TBL] [Abstract][Full Text] [Related]
54. Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the phosphatidylinositol 3-kinase-protein kinase B pathway in diabetic rats.
Ni WJ; Zhou H; Ding HH; Tang LQ
J Diabetes Investig; 2020 Mar; 11(2):297-306. PubMed ID: 31336024
[TBL] [Abstract][Full Text] [Related]
55. Dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis.
Shao X; Zhang X; Hu J; Gao T; Chen J; Xu C; Wei C
Exp Cell Res; 2020 Mar; 388(2):111849. PubMed ID: 31954110
[TBL] [Abstract][Full Text] [Related]
56. 1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway.
Xiao H; Shi W; Liu S; Wang W; Zhang B; Zhang Y; Xu L; Liang X; Liang Y
Am J Nephrol; 2009; 30(1):34-43. PubMed ID: 19202327
[TBL] [Abstract][Full Text] [Related]
57. Tanshinone IIA is superior to paricalcitol in ameliorating tubulointerstitial fibrosis through regulation of VDR/Wnt/β-catenin pathway in rats with diabetic nephropathy.
Zeng JY; Wang Y; Hong FY; Miao M; Jiang YY; Qiao ZX; Wang YT; Bao XR
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3959-3977. PubMed ID: 37991543
[TBL] [Abstract][Full Text] [Related]
58. GSK-3β inhibitor attenuates urinary albumin excretion in type 2 diabetic db/db mice, and delays epithelial-to-mesenchymal transition in mouse kidneys and podocytes.
Wan J; Li P; Liu DW; Chen Y; Mo HZ; Liu BG; Chen WJ; Lu XQ; Guo J; Zhang Q; Qiao YJ; Liu ZS; Wan GR
Mol Med Rep; 2016 Aug; 14(2):1771-84. PubMed ID: 27357417
[TBL] [Abstract][Full Text] [Related]
59. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
Wang S; Li Y; Huang YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
[TBL] [Abstract][Full Text] [Related]
60. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]